XML 17 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Changes to Previously Issued Financial Statements (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Jun. 30, 2011
Sep. 30, 2011
Dec. 31, 2011
As Reported in Prior Period [Member]
           
Net sales $ 202,616 $ 250,012 $ 244,015      
Gross Margin 80,102 95,758 94,900      
Selling, technical, general and research expenses 62,717 62,525 73,726      
Restructuring included in segment operating income 4,861 2,705 2,092      
Operating Income 12,525 30,528 19,082      
Reclassify ADS to Discontinued [Member]
           
Net sales   (43,276) (45,393)      
Gross Margin   (14,470) (16,174)      
Selling, technical, general and research expenses   (11,891) (12,336)      
Restructuring included in segment operating income   (14) (361)      
Operating Income   (2,565) (3,477)      
Merge PMC and EF [Member]
           
Net sales               
Gross Margin               
Selling, technical, general and research expenses               
Restructuring included in segment operating income               
Operating Income               
Reclassify Primaloft to Discontinued [Member]
           
Net sales (5,216) (6,484) (8,941)      
Gross Margin (3,126) (3,226) (4,786)      
Selling, technical, general and research expenses (897) (2,021) (1,661)      
Restructuring included in segment operating income               
Operating Income (2,229) (1,205) (3,125)      
As Adjusted [Member]
           
Net sales 197,400 200,252 189,681 389,635 589,887 787,287
Gross Margin 76,976 78,062 73,940 159,128 237,190 314,166
Selling, technical, general and research expenses 61,820 48,613 59,729 119,809 168,422 230,242
Restructuring included in segment operating income 4,861 2,691 1,731 1,765 4,456 9,317
Operating Income 10,295 26,758 12,480 37,554 64,312 74,608
Paper Machine Clothing [Member] | As Reported in Prior Period [Member]
           
Net sales 163,029 168,067 158,577      
Gross Margin 70,151 72,612 67,373      
Selling, technical, general and research expenses 30,735 24,860 32,016      
Restructuring included in segment operating income 2,339 440 448      
Operating Income 37,077 47,312 34,909      
Paper Machine Clothing [Member] | Reclassify ADS to Discontinued [Member]
           
Net sales              
Gross Margin              
Selling, technical, general and research expenses              
Restructuring included in segment operating income              
Operating Income              
Paper Machine Clothing [Member] | Merge PMC and EF [Member]
           
Net sales (163,029) (168,067) (158,577)      
Gross Margin (70,151) (72,612) (67,373)      
Selling, technical, general and research expenses (30,735) (24,860) (32,016)      
Restructuring included in segment operating income (2,339) (440) (448)      
Operating Income (37,077) (47,312) (34,909)      
Paper Machine Clothing [Member] | Reclassify Primaloft to Discontinued [Member]
           
Net sales               
Gross Margin               
Selling, technical, general and research expenses               
Restructuring included in segment operating income               
Operating Income               
Paper Machine Clothing [Member] | As Adjusted [Member]
           
Net sales                  
Gross Margin                  
Selling, technical, general and research expenses                  
Restructuring included in segment operating income                  
Operating Income                  
Machine Clothing [Member] | As Reported in Prior Period [Member]
           
Net sales               
Gross Margin               
Selling, technical, general and research expenses               
Restructuring included in segment operating income               
Operating Income               
Machine Clothing [Member] | Reclassify ADS to Discontinued [Member]
           
Net sales              
Gross Margin              
Selling, technical, general and research expenses              
Restructuring included in segment operating income              
Operating Income              
Machine Clothing [Member] | Merge PMC and EF [Member]
           
Net sales 183,218 188,334 179,177      
Gross Margin 77,156 79,338 74,953      
Selling, technical, general and research expenses 34,780 27,861 36,672      
Restructuring included in segment operating income 2,465 2,610 572      
Operating Income 39,911 48,867 37,709      
Machine Clothing [Member] | Reclassify Primaloft to Discontinued [Member]
           
Net sales               
Gross Margin               
Selling, technical, general and research expenses               
Restructuring included in segment operating income               
Operating Income               
Machine Clothing [Member] | As Adjusted [Member]
           
Net sales 183,218 188,334 179,177 367,659 555,993 739,211
Gross Margin 77,156 79,338 74,953 161,490 240,828 317,984
Selling, technical, general and research expenses 34,780 27,861 36,672 72,905 100,766 135,546
Restructuring included in segment operating income 2,465 2,610 572 605 3,215 5,680
Operating Income 39,911 48,867 37,709 87,980 136,847 176,758
Doors [Member] | As Reported in Prior Period [Member]
           
Net sales   43,276 45,393      
Gross Margin   14,470 16,174      
Selling, technical, general and research expenses   10,782 11,760      
Restructuring included in segment operating income   14 361      
Operating Income   3,674 4,053      
Doors [Member] | Reclassify ADS to Discontinued [Member]
           
Net sales   (43,276) (45,393)      
Gross Margin   (14,470) (16,174)      
Selling, technical, general and research expenses   (10,782) (11,760)      
Restructuring included in segment operating income   (14) (361)      
Operating Income   (3,674) (4,053)      
Doors [Member] | Merge PMC and EF [Member]
           
Net sales              
Gross Margin              
Selling, technical, general and research expenses              
Restructuring included in segment operating income              
Operating Income              
Doors [Member] | Reclassify Primaloft to Discontinued [Member]
           
Net sales              
Gross Margin              
Selling, technical, general and research expenses              
Restructuring included in segment operating income              
Operating Income              
Doors [Member] | As Adjusted [Member]
           
Net sales                
Gross Margin                
Selling, technical, general and research expenses                
Restructuring included in segment operating income                
Operating Income                
Engineered Fabrics [Member] | As Reported in Prior Period [Member]
           
Net sales 20,189 20,267 20,600      
Gross Margin 7,005 6,726 7,580      
Selling, technical, general and research expenses 4,045 3,001 4,656      
Restructuring included in segment operating income 126 2,170 124      
Operating Income 2,834 1,555 2,800      
Engineered Fabrics [Member] | Reclassify ADS to Discontinued [Member]
           
Net sales              
Gross Margin              
Selling, technical, general and research expenses              
Restructuring included in segment operating income              
Operating Income              
Engineered Fabrics [Member] | Merge PMC and EF [Member]
           
Net sales (20,189) (20,267) (20,600)      
Gross Margin (7,005) (6,726) (7,580)      
Selling, technical, general and research expenses (4,045) (3,001) (4,556)      
Restructuring included in segment operating income (126) (2,170) (124)      
Operating Income (2,834) (1,555) (2,800)      
Engineered Fabrics [Member] | Reclassify Primaloft to Discontinued [Member]
           
Net sales               
Gross Margin               
Selling, technical, general and research expenses               
Restructuring included in segment operating income               
Operating Income               
Engineered Fabrics [Member] | As Adjusted [Member]
           
Net sales                  
Gross Margin                  
Selling, technical, general and research expenses                  
Restructuring included in segment operating income                  
Operating Income                  
Composites [Member] | As Reported in Prior Period [Member]
           
Net sales 14,182 11,918 10,504      
Gross Margin 671 (300) 155      
Selling, technical, general and research expenses 1,254 1,134 1,255      
Restructuring included in segment operating income       44      
Operating Income (583) (1,434) (1,144)      
Composites [Member] | Reclassify ADS to Discontinued [Member]
           
Net sales              
Gross Margin              
Selling, technical, general and research expenses              
Restructuring included in segment operating income              
Operating Income              
Composites [Member] | Merge PMC and EF [Member]
           
Net sales               
Gross Margin               
Selling, technical, general and research expenses               
Restructuring included in segment operating income               
Operating Income               
Composites [Member] | Reclassify Primaloft to Discontinued [Member]
           
Net sales               
Gross Margin               
Selling, technical, general and research expenses               
Restructuring included in segment operating income               
Operating Income               
Composites [Member] | As Adjusted [Member]
           
Net sales 14,182 11,918 10,504 21,976 33,894 48,076
Gross Margin 671 (300) 155 136 (164) 507
Selling, technical, general and research expenses 1,254 1,134 1,255 2,266 3,400 4,654
Restructuring included in segment operating income       44 57 57 57
Operating Income (583) (1,434) (1,144) (2,187) (3,621) (4,204)
Primaloft [Member] | As Reported in Prior Period [Member]
           
Net sales 5,216 6,484 8,941      
Gross Margin 3,126 3,226 4,786      
Selling, technical, general and research expenses 896 1,992 1,621      
Restructuring included in segment operating income               
Operating Income 2,230 1,234 3,165      
Primaloft [Member] | Reclassify ADS to Discontinued [Member]
           
Net sales              
Gross Margin              
Selling, technical, general and research expenses              
Restructuring included in segment operating income              
Operating Income              
Primaloft [Member] | Merge PMC and EF [Member]
           
Net sales               
Gross Margin               
Selling, technical, general and research expenses               
Restructuring included in segment operating income               
Operating Income               
Primaloft [Member] | Reclassify Primaloft to Discontinued [Member]
           
Net sales (5,216) (6,484) (8,941)      
Gross Margin (3,126) (3,226) (4,786)      
Selling, technical, general and research expenses (896) (1,992) (1,621)      
Restructuring included in segment operating income               
Operating Income (2,230) (1,234) (3,165)      
Primaloft [Member] | As Adjusted [Member]
           
Net sales                  
Gross Margin                  
Selling, technical, general and research expenses                  
Restructuring included in segment operating income                  
Operating Income                  
Research [Member] | As Reported in Prior Period [Member]
           
Selling, technical, general and research expenses 8,230 6,400 7,212      
Restructuring included in segment operating income               
Operating Income (8,230) (6,400) (7,212)      
Research [Member] | Reclassify ADS to Discontinued [Member]
           
Selling, technical, general and research expenses              
Restructuring included in segment operating income              
Operating Income              
Research [Member] | Merge PMC and EF [Member]
           
Selling, technical, general and research expenses               
Restructuring included in segment operating income               
Operating Income               
Research [Member] | Reclassify Primaloft to Discontinued [Member]
           
Selling, technical, general and research expenses               
Restructuring included in segment operating income               
Operating Income               
Research [Member] | As Adjusted [Member]
           
Selling, technical, general and research expenses 8,230 6,400 7,212 14,377 20,777 29,007
Restructuring included in segment operating income                  
Operating Income (8,230) (6,400) (7,212) (14,377) (20,777) (29,007)
Non Segment [Member] | As Reported in Prior Period [Member]
           
Gross Margin (851) (976) (1,168)      
Selling, technical, general and research expenses 17,557 14,356 15,206      
Restructuring included in segment operating income 2,396 81 1,115      
Operating Income (20,804) (15,413) (17,489)      
Non Segment [Member] | Reclassify ADS to Discontinued [Member]
           
Gross Margin              
Selling, technical, general and research expenses   (1,109) (576)      
Restructuring included in segment operating income              
Operating Income   1,109 576      
Non Segment [Member] | Merge PMC and EF [Member]
           
Gross Margin               
Selling, technical, general and research expenses               
Restructuring included in segment operating income               
Operating Income               
Non Segment [Member] | Reclassify Primaloft to Discontinued [Member]
           
Gross Margin               
Selling, technical, general and research expenses (1) (29) (40)      
Restructuring included in segment operating income               
Operating Income 1 29 40      
Non Segment [Member] | As Adjusted [Member]
           
Gross Margin (851) (976) (1,168) (2,498) (3,474) (4,325)
Selling, technical, general and research expenses 17,556 13,218 14,590 30,261 43,479 61,035
Restructuring included in segment operating income 2,396 81 1,115 1,103 1,184 3,580
Operating Income $ (20,803) $ (14,275) $ (16,873) $ (33,862) $ (48,137) $ (68,940)